Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navasuja Kumar

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|November 25, 2020
The Appropriateness of Digital Diabetic Retinopathy Screening Images for a Computer-Aided Glaucoma Screening SystemAhmed A Almazroa, Maria A Woodward, Paula Anne Newman-Casey, et al.
Geroscience|August 16, 2022
Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male miceJessica M Snyder, Kerriann M Casey, Andrzej Galecki, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 13, 2023
Physical Resilience as a Predictor of Lifespan and Late-Life Health in Genetically Heterogeneous MiceAshley K Brown, Daniel L Mazula, Lori Roberts, et al.
Aging Cell|March 31, 2021
17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sexDavid E Harrison, Randy Strong, Peter Reifsnyder, et al.
Geroscience|June 19, 2025
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16-hydroxyestradiol, and late‑start canagliflozinRichard A Miller, David E Harrison, Gino A Cortopassi, et al.
Geroscience|July 14, 2024
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16‑hydroxyestriol, and late‑start canagliflozinRichard A Miller, David E Harrison, Gino A Cortopassi, et al.
Geroscience|March 17, 2026
Astaxanthin, meclizine, mitoglitazone, pioglitazone, alpha-ketoglutarate, mifepristone, methotrexate, and atorvastatin-telmisartan do not increase lifespan in UM-HET3 miceRon Korstanje, Randy Strong, Adam B Salmon, et al.
Geroscience|May 16, 2024
Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozinRichard A Miller, David E Harrison, Gino A Cortopassi, et al.
JCI Insight|September 29, 2020
Canagliflozin extends life span in genetically heterogeneous male but not female miceRichard A Miller, David E Harrison, David B Allison, et al.
Geroscience|December 2, 2023
Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules usedDavid E Harrison, Randy Strong, Peter Reifsnyder, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Ophthalmology (Auckland, N.Z.)|November 25, 2020
The Appropriateness of Digital Diabetic Retinopathy Screening Images for a Computer-Aided Glaucoma Screening SystemAhmed A Almazroa, Maria A Woodward, Paula Anne Newman-Casey, et al.
Geroscience|August 16, 2022
Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male miceJessica M Snyder, Kerriann M Casey, Andrzej Galecki, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 13, 2023
Physical Resilience as a Predictor of Lifespan and Late-Life Health in Genetically Heterogeneous MiceAshley K Brown, Daniel L Mazula, Lori Roberts, et al.
Aging Cell|March 31, 2021
17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sexDavid E Harrison, Randy Strong, Peter Reifsnyder, et al.
Geroscience|June 19, 2025
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16-hydroxyestradiol, and late‑start canagliflozinRichard A Miller, David E Harrison, Gino A Cortopassi, et al.
Geroscience|July 14, 2024
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16‑hydroxyestriol, and late‑start canagliflozinRichard A Miller, David E Harrison, Gino A Cortopassi, et al.
Geroscience|March 17, 2026
Astaxanthin, meclizine, mitoglitazone, pioglitazone, alpha-ketoglutarate, mifepristone, methotrexate, and atorvastatin-telmisartan do not increase lifespan in UM-HET3 miceRon Korstanje, Randy Strong, Adam B Salmon, et al.
Geroscience|May 16, 2024
Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozinRichard A Miller, David E Harrison, Gino A Cortopassi, et al.
JCI Insight|September 29, 2020
Canagliflozin extends life span in genetically heterogeneous male but not female miceRichard A Miller, David E Harrison, David B Allison, et al.
Geroscience|December 2, 2023
Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules usedDavid E Harrison, Randy Strong, Peter Reifsnyder, et al.
Pageof 3